73 percent of those new prescription drugs advertised on U.S. television had low therapeutic value, offering only slight benefit over other drugs already on the market, says a recent study. Those drugs accounted for $15.9 billion worth of advertising spending. Of the advertised drugs that had a value rating from Canada, France or Germany, 53 of them were classified as low-benefit, at best.
Back in 2015, the American Medical Association called for an all-out ban on DTC (Direct-to-Consumer) ads for prescription drugs and medical devices, saying they drive demand for expensive treatments despite the clinical effectiveness of less costly alternatives.
More:
“70% of drugs advertised on TV are of “low therapeutic value,” study finds,” Beth Mole, Ars Technica
______________
Short Link: https://wp.me/p6sb6-CXy
Image by Mike Licht. Download a copy here. Creative Commons license; credit Mike Licht, NotionsCapital.com
Comments are welcome if they are on-topic, substantive, concise, and not boring or obscene. Comments may be edited for clarity and length.
Tags: advertising, Big Pharma, direct to consumer advertising, direct to patient advertising, DTP advertising, pharmaceutical industry, prescription drugs, Rx drugs, television, TV
NotionsCapital 
Leave a Reply